Curing cervical cancer or preventing it: A case of opportunity cost in the long run?-Reference-Cited by-同舟云学术

Curing cervical cancer or preventing it: A case of opportunity cost in the long run?

Published:2014-12 Issue:51 Volume:32 Page:6867-6869
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

van de Vooren Katelijne,Curto Alessandro,Garattini Livio

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference16 articles.

1. HPV Information Centre: Publications and technical reports. http://www.hpvcentre.net/hpvpublications.php [accessed 10.06.14].

2. Emerging biological treatments for uterine cervical carcinoma;Vici;J Cancer,2014

3. Improved survival with bevacizumab in advanced cervical cancer;Tewari;N Engl J Med,2014

4. FDA News Release August 14, 2014. FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm410121.htm [accessed 26.09.14].

5. NHS England News. New cervical cancer drug added to Cancer Drugs Fund, 6 March 2014. http://www.england.nhs.uk/2014/03/06/new-cervical-cancer-drug/ [accessed 10.06.14].

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of abnormal pap smears in the western region of Saudi Arabia from 2010 to 2022;Cytojournal;2023-11-23

2. Pricing vaccines and drugs in Europe: worth differentiating?;The European Journal of Health Economics;2020-06-23

3. Identification of Anticancer Compounds from Linum usitatissimum seed Extract and their Effect on HeLa Cells;PHARMACOGN MAG;2020

4. Dutch guidelines for economic evaluation: ‘from good to better’ in theory but further away from pharmaceuticals in practice?;Journal of the Royal Society of Medicine;2017-01-24

5. Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines;International Journal of Cancer;2016-03-22